Abstract
V-abl was first described as the oncogene contained in Abelson murine leukemia virus (A-MuLV), a virus that transforms both lymphocytes and fibroblast lines. The v-abl gene product has a protein tyrosine kinase activity which is essential for the transforming capacity of the virus (Prywes et al. 1983). The normal cellular counterpart, the c-abl proto-oncogene, also encodes a protein with tyrosine kinase activity (Konopka and Witte 1985; Ben-Neriah et al. 1986a). In addition to capture by retroviruses, c-abl can be activated by chromosomal translocations, such as in human chronic myeloid leukemia. In this review we discuss the structure of the c-abl gene, the various transcripts it expresses, and how it is activated to become an oncogene.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abelson HT, Rabstein LS (1970) Lymphosarcoma: virus-induced thymic-independent disease in mice. Cancer Res 30: 2213–2222
Bartram CR (1985) bcr rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia. J Exp Med 162:2175–2179
Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D (1986a) The chronic myelogenous leukemia specific P210 protein is the product of the bcr/abl hybrid gene. Science (in press)
Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D (1986b) Alternative 5’ exons in c-abl mRNA. Cell 44: 577–586
Besmer P, Murphy JE, George PC, Qiu F, Bergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE, Hardy WD (1986) A new transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene. Nature 320: 415–421
Champlain RE, Golde DW (1985) Chronic myelogenous leukemia: Recent advances. Blood 65: 1039–1097
Cook WD (1985) Thymocyte subsets transformed by Abelson murine leukemia virus. Mol Cell Biol 5: 390–397
Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region bcr on chromosome 22. Cell 36: 93–99
Grosveld G, Verwoerd T, Van-Agthoven T, de Klein A, Ramachandran KL, Heisterkamp N, Stam K, Groffen J (1986) The chronic myelocytic cell line K562 contains a breakpoint in bcr gene and its role in the Ph′ translocation. Nature 315: 758–761
Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G (1985) Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 315: 758–761
Hoffman-Falk H, Einat P, Shilo B-Z, Hoffman FM (1983) Drosophila melanogaster DNA clones homologous to vertebrate oncogene: evidence for a common ancestor to the src and abl cellular genes. Cell 32: 589–598
Klar AJS, Strathern JN, Abraham JA (1984) Involvement of double strand chromosomal breaks for mating type switch in Saccharomyces cerevisiae. Cold Spring Harbor Symp Quant Biol 49: 77–88
Konopka JB, Witte ON (1985) Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 5: 3116–3123
Konopka JB, Watanabe SM, Witte ON (1984) An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37: 1035–1042
Kozbor D, Giallongo A, Sierzega ME, Konopka J, Witte O, Showe LC, Croce CM (1986) Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukemia cells. Nature 319: 331–333
Mathey-Prevot B, Baltimore D (1985) Specific transforming potential of oncogenes encoding protein tyrosine kinases. EMBO J 4: 1769–1774
Müller R, Slamon DJ, Tremblay JM, Cline MJ, Verma IM (1982) Differential expression of cellu-lar oncogenes during pre-and postnatal development of the mouse. Nature 299: 640–643
Ponzetto C, Wolgemuth DJ (1985) Haploid expression of a unique c-abl transcript in the mouse male germ line. Mol Cell Biol 5: 1791–1794
Prywes R, Foulkes JG, Rosenberg N, Baltimore D (1983) Sequences of A-MuLV needed for fibroblast and lymphoid cell transformation. Cell 34: 569–579
Rosenberg N, Baltimore D (1976) A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med 143: 1453–1463
Rosenberg N, Baltimore D (1980) Abelson virus in viral oncology (Klein G (ed)), Raven Press, New York 1980
Rowley JD (1975) Nonrandom chromosomal abnormalities in hematologic disorders of man. Proc Natl Acad Sci USA 72: 152–156
Shtivelman E, Lifshitz B, Gale RP, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukemia.. Nature 315: 550–554
Wang JYJ, Baltimore D (1983) Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence. Mol Cell Biol 3: 773–779
Wang JYJ, Ledley F, Goff S, Lee R, Groner Y, Baltimore D (1984) The mouse c-abl locus: molec-ular cloning and characterization. Cell 36: 349–356
Witte ON, Rosenberg NE, Baltimore D (1979) A normal cell protein cross reactive to the major Abelson murine leukemia virus gene product. Nature 281: 396–398
Witte ON, Dasgupta A, Baltimore D (1980) Abelson murine leukemia virus protein is phosphorylated in vitro to form phosphotyrosine. Nature 238: 826–831
Yancopoulos GD, Blackwell K, Suh H, Hood L, Alt FW (1986) Introduced T cell receptor variable region gene segments recombine in pre-B cell: evidence that B and T cells use a common recombinase. Cell 44: 251–259
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ben-Neriah, Y., Baltimore, D. (1986). Normal and Transforming N-Terminal Variants of c-abl . In: Kahn, P., Graf, T. (eds) Oncogenes and Growth Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73325-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-73325-3_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18760-8
Online ISBN: 978-3-642-73325-3
eBook Packages: Springer Book Archive